Skip to main content
Fig. 4 | Breast Cancer Research

Fig. 4

From: Challenges and improvements in HER2 scoring and histologic evaluation: insights from a national proficiency testing scheme for breast cancer diagnosis in China

Fig. 4

Analysis of existing issues of HER2 0, 1 + and 2+. a Average percentages of 169 participants evaluation in individual categories of HER2 0, 1 + and 2+. b The detailed misclassification percentages of HER2 0, 1 + and 2 + evaluation among the 169 participants. c The Weibull distribution of accuracy of sixteen cases with HER2 0, 1 + and 2+. d Detailed scoring results of sixteen cases evaluated by ten participants who showed accuracy rates below 59%

Back to article page